483
ECI Pharmaceuticals, LLCECI Pharmaceuticals, LLC – FDA 483, Jan 27, 2023
Record Details
ECI Pharmaceuticals, LLC in Ft Lauderdale, FL, was inspected regarding its post-marketing adverse drug experience reporting. The inspection revealed significant deficiencies in written procedures for surveillance, evaluation, and electronic submission of adverse drug experience reports. Additionally, the firm failed to submit required annual reports and periodic adverse drug experience reports for an active NDA.
View Company Profile
ID · fa0ab10c-05b1-4bc7-babb-d520a10b6e49
Other documents for ECI Pharmaceuticals, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.